INIFY — INIFY Laboratories AB Balance Sheet
0.000.00%
Last trade - 00:00- NOK339.28m
- NOK279.21m
- SEK1.19m
Annual balance sheet for INIFY Laboratories AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | ARS | ARS |
| Standards: | SAS | SAS |
| Status: | Final | Final |
| Cash | ||
| Cash and Short Term Investments | 129 | 70.9 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 3.11 | 3.69 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Net Property, Plant And Equipment | 9.34 | 9.14 |
| Net Intangible Assets | ||
| Long Term Investments | ||
| Total Other Assets | ||
| Total Assets | 152 | 93 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 13.8 | 7.95 |
| Common Stock | ||
| Other Equity | ||
| Total Equity | 138 | 85 |
| Total Liabilities & Shareholders' Equity | 152 | 93 |
| Total Common Shares Outstanding |